Background. Gastrointestinal motility is impaired in patients with diabetes mellitus (DM). Interstitial cells of Cajal (ICC) in the gastrointestinal tract play a central role in gastrointestinal motility. The present study examined whether ICC density, or expression of neuronal nitric oxide synthase (nNOS)-and substance P (SP)-containing nerves in the gastric antrum, were altered in patients with type 2 DM. Methods. Paraffin-embedded gastric specimens from 51 controls and 36 male DM patients with gastric cancer were used for immunohistochemistry. Serial sections were stained with Kit and mast cell tryptase-specific antibodies. Fresh-frozen gastric specimens from patients with gastric cancer were used for immunofluorescence. The specimens were stained with antibodies to Kit, nNOS, and SP, and levels of expression of these three markers were compared between controls and DM patients. Results. ICC density in the inner circular muscle layer, but not in the myenteric plexus, was lower in patients with severe DM than in controls in paraffin-embedded specimens. In addition, decreased expression of nNOS and SP accompanied by reduced ICC density was observed in frozen specimens from patients with DM. Conclusions. These results suggest that lower gastric ICC, nNOS, and SP densities in patients with DM may be associated with the pathogenesis of diabetic gastroparesis.
Introduction
Impairment of gastrointestinal motility is often observed in patients with diabetes mellitus (DM) and is generally considered to be due to autonomic neuropathy. 1 Diabetic gastropathy is one complication of diabetic dysmotility and is associated with dysphagia, heartburn, nausea, vomiting, and delayed gastric emptying. 2, 3 Interstitial cells of Cajal (ICC) have been identified as pacemakers and mediators of neurotransmission in the gastrointestinal tract, and so have a central role in gastrointestinal motility. 4 In many gastrointestinal motility disorders, such as slow-transit constipation, pseudo-obstruction, infantile hypertrophic pyloric stenosis, Hirschsprung disease, ulcerative colitis, and Crohn's disease, a decrease of ICC density and ultrastructural changes in gastrointestinal muscle are observed. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] A deficiency of ICC and ultrastructural changes in gastrointestinal muscle have been reported in diabetic animal models. 15, 16 A similar deficiency of ICC has also been described in a case report of an insulin-dependent DM patient 17 and a study of seven patients with DM. 18 It remains unclear whether this ICC deficiency in gastrointestinal muscle is related to the disease severity, the presence of any other complications, or the morbidity period. ICC within the gastrointestinal tract possess a number of neurotransmitters; their receptors and modulators, including acetylcholine (M2 and M3 receptors); tachykinins (NK1 and NK3 receptors), vasoactive intestinal peptide-1, heme oxygenase-2, biliverdin reductase, and neuronal nitric oxide synthase (nNOS). 10, 12, [19] [20] [21] [22] [23] [24] [25] Further, ICC are tightly connected to a number of enteric nerves, some of which contain 5-hydroxytryptamine type 3 receptors and substance P (SP). 26, 27 Little is known about the alteration of these receptors, neurotransmitters, and modulators in ICC in patients with DM. A deficiency of nNOS in the gastrointestinal muscle layer and/or delayed gastric empty-ing have been shown in both diabetic animal models [28] [29] [30] [31] and patients with DM. 17 The present study evaluated ICC density in the gastric antrum of patients with DM and whether that ICC density was correlated with disease severity, as measured by hemoglobin A1c (HbA1c). We also determined the expression levels of nNOS and SP in enteric nerves along with ICC, and examined whether they were altered in patients with DM.
Methods

Patients and tissue samples
Paraffin-embedded specimens that had been fixed in 10% formalin were obtained from 123 consecutive patients (control, M/F = 51/28; DM patients, M/F = 36/8) with gastric cancer who underwent gastrectomy at Seirei Hamamatsu General Hospital between 1995 and 2003.
Frozen specimens were obtained from 11 consecutive male patients with gastric cancer who underwent gastrectomy at Hamamatsu University Hospital between 2003 and 2004. None of the patients had undergone preoperative radiotherapy, or had hypothyroidism, irritable bowel syndrome, amyloidosis, or Parkinsonism, and they had no gastrointestinal disorders other than gastric cancer and DM. All specimens in this study were obtained from the anal wedge (prepylorus area) of each resected stomach and did not include any cancerous lesions.
The Human Institutional Review Boards of the Seirei Hamamatsu Hospital and Hamamatsu University School of Medicine approved the research protocol in advance, and the study was performed according to the tenets of the Declaration of Helsinki. Written informed consent was obtained from each patient before the study.
Immunohistochemistry
Paraffin-embedded specimens were sectioned (4 µm thick) and mounted on glass slides. To examine the distribution of mast cells, serial sections were stained either for Kit or for human mast cell tryptase AA1. Immunohistochemical staining was performed using the DAKO ENVISION kit (DAKO, Kyoto, Japan) according to the manufacturer's instructions. Briefly, after deparaffinizing in xylene and rehydrating in ethanol, the sections were heated in citrate buffer (0.01 M, pH 6.0) in a microwave (600 W) for 10 min to retrieve antigens. Next, the sections were incubated with 3% hydrogen peroxide for 10 min to block endogenous peroxidase, before incubating with either the primary rabbit polyclonal anti-c-Kit antibody (1 : 200 dilution; A4502; DAKO) or the primary mouse monoclonal antimast cell tryptase antibody (AA1; 1 : 4000 dilution; M7052; DAKO) overnight at 4°C. The sections were washed with phosphate-buffered saline (PBS) and incubated with secondary antibody (peroxidase-labeled goat polyclonal antibody to rabbit or mouse IgG; K1390; DAKO) for 30 min at room temperature. The sections were washed with PBS, and the labeling was revealed with 3,3-diaminobenzidine and hydrogen peroxide.
Cell count
The number of either Kit-positive or AA1-positive cells in the inner circular muscle (CM) (inner half area) and myenteric plexus (MP) in the antrum was counted in ten randomly selected 0.25 mm 2 fields from each specimen under a microscope (VANOX AHBS3, Olympus, Tokyo, Japan) at a magnification of 200×. Two independent investigators who were blinded to the clinical information counted the number of Kit-positive and AA1-positive cells in each slide. The ICC number was calculated by subtraction of the number of AA1-positive cells, which reflected the mast cell population, from the number of Kit-positive cells.
Immunofluorescence study The resected stomach was gently excised, and approximately 1-cm 2 pieces of tissue were fixed in 4% paraformaldehyde for 24 h at 4°C. The tissue was washed in PBS, immersed overnight at 4°C in PBS supplemented with 30% sucrose, embedded in TissueTek OCT compound (Miles, Elkhart, IN, USA), and frozen at −80°C before use. For the immunofluorescence experiments, the frozen tissue was cut on a cryostat into 8-to 10-µm-thick sections, mounted on silanized slides and air-dried. The immunofluorescence staining was performed using the DAKO CSA2 kit, according to the manufacturer's instructions. Briefly, after incubation in 100% ethanol for 30 min at −20°C to retrieve the antigens, the tissue sections were washed in Tris-buffered saline (TBS) and incubated with 3% hydrogen peroxide for 5 min to block endogenous peroxidase. The sections were washed in TBS and incubated with a nonspecific staining blocking reagent (X0909; DAKO) for 5 min, and incubated with the primary mouse monoclonal anti-c-Kit antibody (1 : 2000 dilution; M7140; DAKO) for 15 min. The sections were washed in TBS supplemented with 0.1% Tween 20 (TBST) and further incubated with the horseradish peroxidase (HRP)-labeled goat secondary anti-mouse antibody (K1497; DAKO) for 15 min. Then, cyanine 3 (Cy3)-labeled tyramide working solution (NEL753; PerkinElmer, Wellesley, MA, USA) was added to the tissue section to amplify the fluorescence signals, and it was incubated for 15 min. Next, the tissue sections were incubated with 3% hydrogen peroxide for 5 min to block residual HRP activity from the initial tyramide signal amplification step. 32 For double immunostaining of Kit with nNOS or SP, the Kit-stained sections were similarly incubated in the nonspecific staining blocking reagent for 5 min, and thereafter incubated with the primary rabbit polyclonal anti-nNOS antibody (1 : 400 dilution; 06-528 Upstate Biotechnology, Waltham, MA, USA) or anti-SP (1 : 1000 dilution; s1542 Sigma, St. Louis, MO, USA) for 15 min. The sections were further incubated with HRP-labeled goat secondary anti-rabbit antibody (1 : 100; P0448; DAKO) for 15 min. Then, fluoresceinlabeled tyramide working solution (NEL753; PerkinElmer) was added to the tissue section to amplify the fluorescence signals, and it was incubated for 15 min.
Confocal laser microscopy
Images of Kit-, nNOS-, and SP-positive cells were obtained using a confocal laser microscope (LSM 510 META, Carl Zeiss Japan, Tokyo, Japan) equipped with a Plan Neofluar 20× objective lens. The confocal fluorescence images were recorded and analyzed with LSM META Examiner software. Three discrete fields 460 µm × 460 µm in the X-Y plane of the CM layer were recorded for each specimen. Optical sections were recorded at 2 µm depth. We used a 488-nm laser line with a 505-nm band-pass and a 560-nm long-pass filter for detection of fluorescein, and a 543-nm laser line with a 530-nm band-pass and a 560-nm long-pass filter for detection of Cy3. All confocal fluorescence images were recorded at the same contrast and brightness.
The percentage ratio of the fluorescence-positive area per field was evaluated in control and DM specimens and defined as the density of each fluorescent label. This was calculated for each fluorescent label (Kit, nNOS, SP, and the colocalized area of Kit and nNOS) with the following equation: percentage fluorescence immunopositive area (%) = fluorescence immunopositive area/grid area (460 µm × 460 µm) × 100. Similarly, the percentage ratio of the colocalized area with Kit and nNOS relative to the Kit-positive area was calculated as: nNOS immunopositive area per Kit immunopositive area (%) = the merged area of Kit and nNOS/Kit-immunopositive area × 100.
Statistical analysis
All numerical data are expressed as means ± SEM. Statistical differences between controls and patients with DM were assessed Student's t test. Differences in the number of ICC among three groups (controls, mild DM, and severe DM) were assessed by one-way analysis of variance followed by Scheffe's multiple comparison test. All P values were two-tailed, and P < 0.05 was considered statistically significant.
Results
ICC number is decreased in patients with DM
In control subjects, most Kit-positive cells were observed within the inner muscle layer (Fig. 1A) and the MP region (Fig. 1C) of the stomach. Kit-positive cells were round or fusiform. AA1-positive mast cells were mainly distributed in the mucosa and submucosa, while a few AA1-positive mast cells were observed in the inner muscle layer (Fig. 1B) and MP region (Fig. 1D ) of the stomach. In patients with DM, the Kit-positive and spindle cells were sparsely distributed in the MP region ( Fig. 1G ) and within the inner muscle layer (Fig. 1E ) of the antrum, while a few AA1-positive mast cells were observed in the inner muscle layer (Fig. 1F ) and MP region (Fig. 1H ) of the stomach.
Within the control specimens, there were significantly fewer intramuscular ICC (ICC-IM) in the inner circular layer in women (mean 104.8 ± 9.8 per 2.5 mm 2 , n = 28) than in men (147.4 ± 11.4 per 2.5 mm 2 , n = 51) (P < 0.05) (Fig. 2) . This difference, and the fact that there were very few specimens collected from female DM patients led us to evaluate only material from male patients. On the other hand, within the male control specimens, the ICC-IM number in the inner circular layer was not correlated with age (data not shown).
The 87 male patients were classified into three groups according to HbA1C levels: control (HbA1c ≤ 5.8), mild DM (5.9 ≤ HbA1c ≤ 7.9), and severe DM (8 ≤ HbA1c). The border between mild and severe was chosen arbitrarily. The characteristics of the 51 male controls and the 28 mild DM and 8 severe DM patients are summarized in Table 1 .
The mean ICC-IM number in the inner circular layer was significantly lower in patients with severe DM (66.1 ± 23.3 per 2.5 mm 2 , n = 8) than in controls (147.4 ± 11.4 per 2.5 mm 2 , n = 51) (P < 0.05), but there was no (Fig. 3A) , n = 8) (P > 0.05) (Fig. 3B) . The mean ICC number was not significantly correlated with morbidity duration, the presence of triopathy, drug administration, or insulin use (Table 2) .
Decreased expression of nNOS and SP was accompanied by reduced ICC levels in patients with DM
We measured the density of the colocalized area for Kit and nNOS in the inner CM of six male controls (HbA1c ≤ 5.8) and five male patients with DM (6.5 ≤ HbA1c). In controls, most of the Kit-, nNOS-and SP-positive cells were located in the MP region and within the inner muscle layer of the antrum (Figs. 4A, B, 5A, B) . In contrast, Kit-, nNOS-and SP-positive cells were The data are shown as means ± SEM; *P < 0.05, **P < 0.01 sparsely observed in the same region and layers in patients with DM (Figs. 4D, E, 5D, E). As shown in Fig.  3A , the density of Kit-positive cells in the inner CM of the antrum was lower in DM patients (2.59 ± 0.35%) than in controls (4.24 ± 0.56%, P < 0.05) (Fig. 6A) . The density of nNOS-positive cells in the inner CM of the antrum in DM patients was also significantly lower than that in controls (0.41 ± 0.18% versus 2.06 ± 0.33%; P < 0.01) (Fig. 6B) . The merged area of Kit and nNOS per field was expressed as a percentage of the field area and referred to as the colocalized density. The colocalized density was significantly lower in DM patients than in controls (0.05 ± 0.02% versus 0.44 ± 0.1%; P < 0.01) (Fig. 6C) . Further, the proportion of the nNOS-positive area within the Kit-positive area was significantly lower in patients with DM than in controls (1.82 ± 0.79% versus 10.26 ± 1.86%; P < 0.01) (Fig. 6D) . Density of either Kit or SP in the inner CM of the antrum in DM patients was significantly lower than in controls (2.25 ± 0.18% versus 4.39 ± 0.29%, P < 0.01; 0.07 ± 0.01% versus 0.52 ± 0.06%, P < 0.01, respectively) (Fig. 7A, B) .
Discussion
Gastropathy is one of the dysmotility complications that can result from the diabetic condition. 2, 3 However, the pathogenesis of diabetic gastropathy is not clear. Recent studies on ICC in human have proposed novel hypotheses for the etiology of motility disorders in relation to the loss of ICC. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] 17, 18 In the present study, we evaluated ICC in the gastric antrum in relation to nNOS and SP in patients with or without DM and obtained three major findings. First, ICC-IM in the inner circular layer of the antrum in patients with DM was lower than those of controls. Second, the expression of nNOS and SP, accompanied by a deficiency of Kit-positive areas, in the inner CM of the antrum was decreased in patients with DM. Third, a sex difference was observed in ICC-IM density in the inner circular layer of the antrum.
The mean ICC-IM number in the inner circular layer appeared to decrease with the severity of DM. A statistically significant difference was observed between the ICC-IM number in controls and severe DM patients. Although several reports have demonstrated that ICC density in gastrointestinal smooth muscles is decreased in both diabetic animal models 15 and patients with DM, 5, 17, 18 this is the first study to evaluate the relationship between gastric ICC density and the severity of DM. We observed a significant decrease in ICC density in DM patients, which was correlated with severity. Since a delay of gastric emptying is reported in DM patients, 3 a decrease in ICC density may be one factor underlying the pathogenesis of gastric dysmotility in DM patients. In the present study, the mean ICC number was not correlated with the duration of morbidity, the presence of triopathy, drug administration, or insulin use. Since insulin and IGF-1 have been reported to prevent an ICC decrease during high glucose supplementation, 33 it is possible that ICC number is sustained in patients with DM whose blood glucose values are successfully regulated by medication.
In contrast to the ICC-IM result, the mean number of ICC in the MP (ICC-MP) of the antrum was not signifi- Several studies have shown that the expression of nNOS or SP is decreased in the gastrointestinal muscle of diabetic animals, [28] [29] [30] [31] 35, 36 but none have examined whether nNOS or SP expression is altered in DM patients concomitant with ICC density. Consistent with previous reports, [28] [29] [30] [31] 35, 36 the present study showed that nNOS and SP expression were both significantly decreased in the antrum of patients with DM. Further, there was a substantial decrease in the colocalized area of Kit with nNOS, implying the possible impairment of nitrergic inhibitory neurotransmission via ICC. Studies have shown that nNOS-immunopositive nerve fibers are closely associated with ICC-IM morphologically, 23, 25 and that ICC-IM play a role in NO-dependent inhibitory neurotransmission in the lower esophageal and pyloric sphincters. 24 In contrast, in c-kit mutant mice, ICC are absent in the pyloric sphincters, whereas the distribution of NOS-containing nerves is normal. 24 On the other hand, ICC are normally distributed throughout the gastrointestinal tract in glial cell line-derived neurotrophic factor knockout mice, 37 which do not develop enteric nerves. These findings suggest that the presence of ICC is not required for the development of enteric neurons, and that the presence of enteric neurons is not required for the development of ICC. Here, it was demonstrated that both ICC and nNOS densities were decreased in patients with DM. Although little is known about the mechanism underlying decreased ICC and nNOS in patients with DM, our findings suggest that a common factor or factors induce the loss of both ICC-and nNOS-containing nerves in the diabetic condition.
There is a known sex difference in the morbidity of dysmotility syndromes. It has been shown that the morbidity of functional dyspepsia, 38 irritable bowel syndrome, [39] [40] [41] [42] and chronic constipation, 43 is higher in women, although the pathogenesis of these dysmotility syndromes remains unclear. Little is known about whether there is a sex difference in ICC density in gastrointestinal muscle, and further study is required to solve this problem.
In conclusion, we showed that the density of ICC and expression of nNOS and SP in the gastric antrum were decreased in patients with DM. We assume that the loss of ICC in patients with DM is associated with the gastroparesis often seen in these patients. However, the results of the present study must be interpreted within the context of the study's limitations. First, we could not measure gastric emptying in patients. Therefore, we could not confirm that they did have gastric dysmotility. Second, all patients had undergone gastrectomy for gas- tric cancer. Although the tissue samples used in the present study were distinct from cancer lesions and there has been no report of a correlation between ICC distribution and gastric cancer, we cannot be certain that the results can be extrapolated to patients without gastric cancer. Therefore, our study should be considered preliminary, and further study is required to elucidate the causal relationship between the loss of ICC and gastric dysmotility in patients with DM. Our results have potential implications for understanding dysmotility syndromes observed in patients with DM.
